The landscape of dementia prognosis has developed considerably with the advent of complex biomarkers, like amyloid PET scans, tau imaging, and blood-based tests that could detect Alzheimer's pathology several years before signs or symptoms arise. Although these technological advancements depict amazing progress in knowing neurodegenerative diseases, they have not diminished https://bobl419gpy8.blog-eye.com/profile